Efficacy and Safety of Intra-articular Injections of Hyaluronic Acid Combined With Polydeoxyribonucleotide in the Treatment of Knee Osteoarthritis

Abstract

Objective To assess the clinical efficacy and safety of intra-articular injection of hyaluronic acid (HA) combined with polydeoxyribonucleotide (PDRN) in patients with knee osteoarthritis in comparison with that of HA alone. Methods The current single-center, prospective, randomized, double-blind, controlled study was conducted in 36 patients with knee osteoarthritis at our medical institution. All the eligible patients (n=30) were equally assigned to two treatment arms (trial group ‘HA+PDRN’ and control group ‘HA’). For efficacy assessment, the patients were evaluated for the visual analogue scale (VAS) scores, the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the Knee Society Scores (KSS), all of which served as efficacy outcome measures. We monitored time-dependent changes in efficacy outcome measures at baseline and 1, 3 and 6 months. Subsequently, we compared differences in changes in efficacy outcome measures at 6 months from baseline between the two groups. Moreover, we assessed the safety based on the treatment-emergent adverse events (TEAEs), adverse drug reactions (ADRs) and any other complications serving as safety outcome measures. Results There were significant differences in changes in the VAS scores, the WOMAC scores in all domains, except ‘Stiffness’, the total WOMAC scores, and the KSS scores in all the domains at 6 months from baseline between the two groups (p<0.05). In our series, there were no TEAEs, ADRs, and any other complications. Conclusion Intra-articular injections of HA combined with PDRN can also be considered in the treatment of knee osteoarthritis. However, further large-scale and multi-center studies are required to demonstrate the potential of the proposed combination.

Mesenchymal Stem Cells Use in the Treatment of Tendon Disorders: A Systematic Review and Meta-Analysis of Prospective Clinical Studies

“…Kinnaird et al [ 23 ] found that the growth of endothelial cells and smooth muscle cells may be promoted by the use of medium conditioned with MSCs. This phenomenon might be partly explained by the presence of VEGF (vascular endothelial growth factor) and bFGF (basic fibroblast growth factor), which appeared in high levels in a MSC-conditioned medium [ 24 ]. They can recruit macrophages and endothelial cells into the injured site, allowing enhancement of the healing process.…”

Adenosine A2A receptor agonist polydeoxyribonucleotide ameliorates short-term memory impairment by suppressing cerebral ischemia-induced inflammation via MAPK pathway

“…The adenosine A 2A receptor agonist, polydeoxyribonucleotide (PDRN), exhibits an anti-inflammatory effect by inhibiting pro-inflammatory cytokine production. PDRN is also known to inhibit apoptosis in several disease states such as gastric ulcers, acute lung injury, and osteoarthritis [ 16 – 18 ]. Despite the excellent pharmacological effects of PDRN, few studies have evaluated the efficacy of PDRN in cerebral ischemia.…”

Applications of Marine Organism-Derived Polydeoxyribonucleotide: Its Potential in Biomedical Engineering

“…A 2018 study confirmed the preventive effect of Ok-PDRN on post-surgery scar formation [ 58 ]. Forty-four patients who underwent open total thyroidectomy were subjected to a combined therapy consisting of fractional laser treatment (48 J/16 cm 2 ) and Ok-PDRN injections during the first four weeks after surgery, after which Ok-PDRN injections were administered for an additional 2-week period.…”